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Ella Arensman n,o,p,w,*, Benedikt L. Amann a,b,g,h,v 
a Centre Fòrum Research Unit, Institut de Neuropsiquiatria i Addiccions (INAD), Parc de Salut Mar, Barcelona, Spain 
b IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain 
c PhD Programme, Department of Psychiatry and Forensic Medicine, School of Medicine Universitat Autònoma de Barcelona, Barcelona, Spain 
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i Population Health, London School of Hygiene and Tropical Medicine, London, England 
j Global Public Health, Public Health England, United Kingdom 
k LUCAS, Centre for Care Research and Consultancy, University of Leuven, Belgium 
l Institute of Behavioral Sciences, Semmelweis University, Budapest, Hungary 
m Mental Health Center Prizren, Kosovo 
n School of Public Health, College of Medicine and Health, National Suicide Research Foundation, University College Cork, Ireland 
o National Suicide Research Foundation, Cork, Ireland 
p Australian Institute for Suicide Research and Prevention, Griffith University 
q Nursing, Midwifery and Allied Health Professions Research Unit, University of Stirling, Scotland, United Kingdom 
r Department of Public Health, Faculty of Medicine, University of Medicine, Tirana, Albania 
s Phrenos Center of Expertise for severe mental illness, Utrecht, the Netherlands 
t Research Centre of the German Depression Foundation, Leipzig, Germany 
u Department of Psychiatry, Psychosomatics and Psychotherapy, Goethe-Universität Frankfurt, Frankfurt, Germany 
v Institut de Neuropsiquiatria i Addiccions (INAD), Hospital del Mar, Barcelona, Spain 
w International Association for Suicide Prevention (IASP), Washington DC, USA 
x Department of Clinical Psychology and Psychotherapy, University of Heidelberg, Heidelberg, Germany 
y Health Service Executive, Cork, Ireland   






Small- and medium-sized enterprises 
A B S T R A C T   
Background: Depression and anxiety are the most prevalent mental health difficulties in the workplace, costing 
the global economy $1 trillion each year. Evidence indicates that symptoms may be reduced by interventions in 
the workplace. This paper is the first to systematically review psychosocial interventions for depression, anxiety, 
and suicidal ideation and behaviours in small-to medium-size enterprises (SMEs). 
Methods: A systematic search following PRISMA guidelines, registered in PROSPERO (CRD42020156275), 
was conducted for psychosocial interventions targeting depression, anxiety, and suicidal ideation/behaviour in 
SMEs. The PubMed, PsycINFO, Scopus, and two specific occupational health databases were searched, as well as 
four databases for grey literature, without time limit until 2nd December 2019. 
Results: In total, 1283 records were identified, 70 were retained for full-text screening, and seven met the 
inclusion criteria: three randomised controlled trials (RCTs), three before and after designs and one non- 
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randomised trial, comprising 5111 participants. Study quality was low to moderate according to the Quality 
Assessment Tool for Quantitative Studies. Five studies showed a reduction in depression and anxiety symptoms 
using techniques based on cognitive behavioural therapy (CBT), two reported no significant change. 
Limitations: Low number and high heterogeneity of interventions and outcomes, high attrition and lack of 
rigorous RCTs. 
Conclusions: Preliminary evidence indicates CBT-based interventions can be effective in targeting symptoms of 
depression and anxiety in SME employees. There may be unique challenges to implementing programmes in 
SMEs. Further research is needed in this important area.   
1. Introduction 
Depression and anxiety are the most prevalent mental health diffi-
culties in the workplace, and the impact of depression and anxiety dis-
orders on the global economy is €1 trillion each year in lost productivity 
(World Health Organization, 2019). In the European Union (EU), 
approximately one in six people suffer from mental health disorders 
annually (OECD and European Union, 2018), with depression being the 
most disabling disorder in terms of years lost to ill-health, disability or 
premature death, and anxiety disorders the most prevalent (Wittchen 
et al., 2011). 
Workplace-based psychosocial interventions aimed at preventing 
and treating depression and anxiety can help reduce these social and 
financial costs. Interventions based on cognitive-behavioural therapy 
(CBT) are the most studied and therefore have the best evidence for 
reducing symptoms of depression and anxiety (Joyce et al., 2016; 
Nigatu et al., 2019; Richardson and Rothstein, 2008; Yunus et al., 2018). 
However, small- to medium-sized enterprises (SMEs) are less likely to 
implement health promotion programmes (McCoy et al., 2014). One 
possible reason is that SMEs may be motivated more by company-related 
factors than humanitarian motives and may lack knowledge regarding 
the related impact on business (Hughes et al., 2011). They also lack the 
capacity larger companies possess to implement workplace in-
terventions (Hannon et al., 2012), and to manage the return to work of 
those on sick leave due to mental health problems (Koopmans et al., 
2008). In the EU, SMEs are defined as employing 250 people or less 
(European Union Commission, 2003) and in 2015 they accounted for 
92.8% of the EU’s non-financial business economy (approximately 91 
million people; Eurostat, 2018). SMEs are also more vulnerable to 
financial and economic crises, as observed in the current COVID-19 
pandemic (OECD, 2020), yet there is surprisingly little data regarding 
depression and anxiety in SMEs, or interventions targeted at this 
workforce. 
This paper aims to fill a gap in the existing research by systematically 
reviewing the literature about the current evidence for interventions 
targeting depression, anxiety, and suicidal ideation and behaviour in the 
SME workplace. 
2. Methods 
2.1. Search strategy and selection criteria 
A systematic review was conducted addressing the following inclu-
sion criteria: (1) study sample included employees or owners/managers 
of companies specified as SMEs; (2) the intervention was psychosocial 
(defined as “interpersonal or informational activities, techniques, or 
strategies that target biological, behavioural, cognitive, emotional, 
interpersonal, social, or environmental factors with the aim of 
improving health functioning and wellbeing”; (Institute of Medicine of 
the National Academies, 2015, p. 32); (3) mental health outcomes were 
measured in terms of symptoms of depression, anxiety and/or suicidal 
ideation/behaviour; (4) quantitative or qualitative data comparing 
baseline and post-intervention data; (5) published in English; and 6) the 
intervention was delivered through the workplace. 
PsycINFO, PubMed, and Scopus and two occupational health 
databases, NIOSHTIC-2 from the National Institute for Occupational 
Safety and Health and CISDOC from the International Labour Organi-
zation, were searched for primary literature. BIOSIS Previews, Clinical 
Trials, the Cochrane Central Register of Controlled Trials and the In-
ternational Standard Randomised Controlled Trial Number Registry 
were searched for unpublished data. Searches were performed from the 
beginning of records until 2nd December 2019. Reference lists were 
further searched for additional literature. The search strategy (please see 
Supplementary Material 1) comprised three categories, including key-
words relating to SMEs, keywords relating to psychosocial interventions, 
and outcomes related to depression, anxiety, and/or suicidal ideation or 
behaviour. 
2.2. Screening procedure 
Results were screened in a two-stage procedure by two independent 
researchers (BH and IGS) and discrepancies resolved in a consensus 
meeting with a third (JCM). The quality of studies was assessed using the 
Quality Assessment Tool for Quantitative Studies (QATQS; Thomas 
et al., 2004) following a similar procedure of independent review and a 
consensus meeting. 
2.3. Data extraction 
Data extraction from selected studies included number of partici-
pants (intention-to-treat and completers), intervention and control 
condition characteristics, outcomes in terms of changes in symptoms of 
depression, anxiety, and suicidal ideation or behaviour, time points for 
data evaluation, country, and sector. Due to the small number of studies, 
and high heterogeneity of both interventions and outcomes, a meta- 
analysis could not be performed. However, whenever studies provided 
data necessary to compute effect sizes and these were not already re-
ported, they were estimated using Higgins and Green’s formulas (Hig-
gins and Green, 2011). In some studies, data were missing regarding 
effect sizes or details of the intervention carried out. In these cases, study 
authors were contacted, and data included if information was provided. 
The review was conducted according to PRISMA guidelines (Moher 
et al., 2009) and registered with PROSPERO: CRD42020156275. 
3. Results 
The initial systematic search yielded 1396 results, which was 
reduced to 1283 once duplicates were removed. Following the title/ 
abstract screening, 70 full-text articles were retrieved. Seven studies met 
inclusion criteria. The detailed process is shown in the PRISMA flow 
diagram (Fig. 1). The included studies comprised three randomised 
controlled trials (RCTs), three before and after study designs and one 
non-randomised trial, with a total of 5111 participants. 
An overview of the characteristics of the included studies is pre-
sented in Table 1. Five studies trialled CBT-based interventions (Blonk 
et al., 2006; Kim et al., 2014; Martin et al., 2020; Saraf et al., 2019; 
Sørensen et al., 2019), ranging from self-administered to face-to-face 
support. One large study employed CBT-based psychotherapy as well 
as other unspecified psychotherapy techniques (Demou et al., 2018). In 
another case the intervention had been run by an external company and 
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they were unable to specify what techniques were used (Schwatka et al., 
2018). Study samples ranged from SME employees, entrepreneurs and 
managers to those who were self-employed across a wide range of sec-
tors and countries. All companies were SMEs of <250 employees except 
in the study by Kim and colleagues (Kim et al., 2014), in which a 
company of 295 people was considered an SME according to local 
Korean standards (Kim, 2007). None of the studies included suicidal 
behaviour/ideation as an outcome. All studies relied on self-reported 
measures of the outcomes with only two of them including a diag-
nostic interview at baseline (Blonk et al., 2006; Sørensen et al., 2019), of 
which one excluded participants with major depressive disorder and 
anxiety disorders (Blonk et al., 2006). Thus, the results refer to changes 
in symptoms of depression and anxiety but not to effectiveness in clinical 
depression and anxiety. In three studies the intervention was aimed at 
SME employees but delivered outside the physical workplace (Blonk 
et al., 2006; Demou et al., 2018; Sørensen et al., 2019), either due to 
employees being on sick leave or by making use of local psychiatric 
services. These studies included the only two in which clinical diagnoses 
of mental disorder were made and were included as relevant to 
addressing more severe mental health issues in the workplace. The re-
sults are presented in Table 2. 
All three RCTs (Blonk et al., 2006; Martin et al., 2020; Saraf et al., 
2019) evaluated CBT-based interventions. An Australian study (Martin 
et al., 2020) with an overall sample of 297 SME owners from a wide 
range of sectors compared three treatment conditions: (1) a 
self-administered DVD and resource kit based on CBT stress manage-
ment techniques, (2) the aforementioned plus telephone support, and 
(3) a wait-list active control group who received psychoeducational 
information only. Both the self-administered DVD plus telephone sup-
port (Change=− 2.5, 95% CI [− 4.1, − 0.9]; p = 0.002) and active control 
(Change=− 1.5, 95% CI [− 2.7, − 0.2]; p = 0.02) led to a significant 
decrease in the Kessler 10 measure of psychological distress from pre- to 
post-treatment, while the self-administered only group showed no sig-
nificant reduction (Change=− 1.3, 95% CI [− 2.9, − 0.4]; p>0.05). The 
effect size in the self-administered plus telephone group was moderately 
greater than in the active control group (Hedge’s g = 0.35; CI [− 0.054, 
0.763]), while the remaining comparisons did not even reach small ef-
fect sizes. Another RCT from Pakistan (Saraf et al., 2019) recruited 235 
subjects from amongst beneficiaries of a cash grant programme to 
re-establish businesses in a wide range of sectors in a conflict-affected 
area, in a context of conflict, fragility and violence. The study 
compared five CBT group sessions lasting three hours each, plus the cash 
grant, with a control group who received the financial grant only. Par-
ticipants in the treatment group had a greater (but not significant) 
reduction in a composite score of anxiety (General Anxiety Disorder-7) 
and depression (Patient Health Questionnaire-9) symptoms at five 
weeks post-intervention (n.s., p value not reported) and at three-month 
follow-up (p = 0.087) compared to the control group. 
With 122 participants, a Dutch RCT (Blonk et al., 2006), conducted 
in self-employed workers and entrepreneurs across a wide range of 
sectors with adjustment disorders, compared: (1) individual CBT con-
sisting of 11 two-weekly 45 min sessions;( 2) a combined intervention 
comprising CBT-based stress management techniques and advice 
delivered by a labour expert comprising five or six twice-weekly 
hour-long sessions, and (3) a control group who received two GP 
checks four months apart. A significant decrease between baseline and 
4-months follow up on the Depression Anxiety and Stress Scale was 
found in all three study arms (p<0.01). Furthermore, this was main-
tained in all groups at 10-month follow-up (p<0.01). In terms of return 
to work, participants in the combined treatment condition achieved a 
Fig. 1. PRISMA flow diagram.  
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Table 1 
Overview of study characteristics.  
Author/ 
Year 
Study Design Population 
No. Started (No. 
Completers) 








122 (98) self- 
employed people 
on sick leave 
81% male/19% female 39% agricultural, 18% 
service, 12% 
construction, 8% health 
care, 8% trade, and 15% 
other. 
1) individual combined 
intervention of brief CBT- 
based stress management 
and advice on work 
processes, carried out by a 
labour expert (n=40)2) 
Individual CBT therapy 
using protocol for treatment 
of burnout or other 
adjustment disorders (n=40) 
3) Control: visits with a 
general practitioner to check 
legitimacy of sickness claim. 
(n=42)  
1) 5-6 twice a 
week sessions of 
approx. 60 mins 
2) 11 two- 
weekly sessions 
of approx. 45 
mins 
3) 2 sessions 4 
months apart 
Netherlands 




252 (211) white- 
and blue-collar 
workers from one 
medium-sized 
company 
White collar: 80.2% 
male/19.8% female  
Blue-collar: 100% male 
Metal-forging Dissemination of stress- 
management information 
including CBT techniques, 
anger management, 





Subgroup: Individual stress 
reduction aimed at 
improving coping skills 
(n=24) 
Info distributed 
7 times over 7 
weeks. 
Workshop: 3 x 2 
hour sessions 
over 1 week 
Subgroup: 5 








employees of small 






















Worksite Wellness Program 
comprising telephone health 
counselling and resource 
material aimed at improving 














1986 (1696) self- 
employed and SME 
employees 
48% female/51% male/ 
0.6% not specified or 
data missing  
Service for all SME 
employees in catchment 
area 
Telephone-based case 
management and some face- 





31-180 days, 2% 
>365 days 
Scotland 




235 (210) SME 
entrepreneurs. 87% 
of firms were ≤ 20 
employees 






17% retail, 12.9%/ 
17.8% services, 5.1%/ 
6.8%wholesale, 35%/ 
27.1% other 
1) Financial grant plus CBT 
in face-to-face group setting 
led by trainer and co- 
facilitator (n=118) 
2) Financial grant only 
(control) (n=117) 















Clinical cases: 42.1% 
male/57.9% female; 
subclinical cases: 65% 
male/35% female; 




education and finance 
1) Clinical cases of 
depression and anxiety (Dx 
from PSE plus HAM-D 18+
or HAM-A 
20+) → psychiatric 
treatment based on standard 
protocols until remission 
achieved (n=38) 
2) Subclinical cases (HAM-D 
13-17/ HAM-A 15- 
19) → CBT focused on stress- 
reduction and resilience 
(n=20) 
3) Controls comprising 
healthy controls (n=513) 
















297 (147) SME 
owner/managers 
Control: 43% male/ 
57% female; DVD + kit; 




1) self-administered DVD: 
psychoeducation and stress- 




(continued on next page) 
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full return to work approximately 80 days (mean average) earlier than 
those in the CBT or control group (Cohen’s d = 0.64 and d = 0.62 
respectively, p<0.01), and a partial return to work approximately 55 
days sooner than in the CBT or control group (d = 0.55 and d = 0.50 
respectively, p<0.01). However, the latter was not significant after 
adjusting for gender, age, education, and the number of employees. 
Of the four non-RCT studies, a longitudinal non-randomised Danish 
trial (Sørensen et al., 2019) allocated 586 subjects from 6 SMEs from 
various sectors to different study conditions based on clinical status 
determined through clinical interview. All employees with clinical 
symptoms were referred to treatment based on standard protocols 
consisting of psychotherapy and medical consultations, with a mean 
duration of 369 days. Employees with subclinical symptoms were 
referred to an individual CBT psychotherapy of a mean duration of 103 
days aimed at preventing the onset of clinical disorder. Employees not 
meeting these symptom criteria were assigned to the heathy control 
group. In both active treatment conditions, there was a reduction in 
symptoms identified with the Symptom Checklist 90-R when comparing 
baseline with 12-month follow up (d = 0.49, p<0.001 for depression; d 
= 0.50, p = 0.004 for anxiety; and d = 0.55, p<0.001 for global severity 
for the clinical cases; d = 0.40, p = 0.036 for depression; d = 0.46, p =
0.064 for anxiety; and d = 0.52, p = 0.041 for global severity for the 
sub-clinical cases). Those who refused treatment showed a significant 
reduction in depression (d = 0.29, p = 0.009) and global severity (d =
0.56, p = 0.002), but not anxiety, despite the larger effect size (d = 0.82, 
p = 0.07); it is unknown if they pursued treatment options outside the 
study. Healthy controls with no clinical or subclinical condition at 
baseline showed no significant change in depressive symptoms (d =
0.12, p = 0.472), anxiety (d = 0.16, p = 0.096), or global severity (d =
0.19, p = 0.967). 
In a retrospective Scottish study (Demou et al., 2018), a four-year 
evaluation was carried out into the effectiveness of a programme of 
telephone-based case management and face-to-face therapeutic support, 
including CBT and other psychological therapies, aimed at assisting 11, 
748 SME employees from a range of sectors with health problems 
ranging from mental health conditions to musculoskeletal disorders. Of 
these, a sub-section of 1696, based on the symptoms they showed, were 
asked to fill out the Hospital Anxiety and Depression Scale (HADS). 
Thirty percent had a baseline score on the HADS indicative of depres-
sion, and 44% had a baseline score on the HADS indicative of an anxiety 
disorder, although a self-report scale does not confirm clinical diagnosis. 
There was a significant reduction in levels of depression symptoms 
post-intervention compared to baseline as measured by the HADS (d =
1.74, p<0.001 for all participants; d = 1.57, p<0.001 for participants 
presenting primarily with a mental health condition) and anxiety 
symptoms (d = 0.90, p<0.001 for all; d = 1.80, p<0.001 for participants 
presenting primarily with a mental health condition). Data regarding 
number of working days lost while participating in the programme was 
available for 291 participants with a mental health condition and 
showed a mean average of 44.0 days. Of 956 participants with a mental 
health condition, 83% thought this was resolved at discharge from the 
programme. However, there was no control group against which to 
compare these statistics. 
Schwatka et al. (2018) used data from a large USA before and after 
study comprising a total sample of 1935 employees of SMEs from 
different sectors who had implemented the Worksite Wellness Program, 
comprising annual health risk assessments, unlimited telephone coun-
selling and access to educational resources, to assess if it could improve a 
range of health indicators including self-reported presence or absence of 
depression. Participating businesses also received organisational level 
feedback and action plans. In small businesses (<50 employees) there 
was a reduction in the number of participants reporting depression at 
one-year follow-up as compared to baseline (OR=0.71, 95% CI [0.55, 
0.92]). This trend was maintained at two years, with no changes as 
compared to one year follow up (OR=1.00, 95% CI [0.50, 2.02]). In 
small-medium businesses (50–99 employees) there was also a reduction 
in self-reported depression at one-year follow up (OR=0.91, 95% CI 
[0.73, 1.14]). Furthermore, the reduction was evident at two year follow 
up compared to one year follow up (OR=0.80, 95% CI [0.57, 1.11]). 
A study carried out in South Korea (Kim et al., 2014) applied an 
intervention in one metal-forging company using a before and after 
design. This study combined an organisational approach, consisting of 
employee workshops to brainstorm company-wide improvements, with 
a psychosocial approach comprising the dissemination of stress man-
agement information based on CBT. In addition, a reduced proportion of 
the company, either selected because of high scores on the Worker’s 
Stress Response Inventory (WSRI) or a sleep questionnaire or volunteers, 
also received individual CBT-based stress reduction sessions. The au-
thors analysed data for the whole sample and found no significant 
decrease in depressive symptoms measured with the WSRI as compared 
to baseline (d = 0.12, p = 0.177 for blue-collar; and d = 0.12, p = 0.247 
for white-collar workers), despite reporting short-term improvements in 
a range of psychosocial factors implicated in job stress. 
4. Discussion 
To our knowledge, this is the first systematic review to evaluate 
psychosocial interventions targeted at reducing depression and anxiety 
among SME employees and owner/managers. Following a systematic 
search of a broad range of sources, we identified seven relevant studies. 
Depressive symptoms were the most studied outcome followed by anx-
iety symptoms, and only one study confirmed clinical anxiety and 
depression at baseline. None of the studies reported outcome data on 
suicidal ideation or behaviour. Thus, the results provide an indication of 
the effectiveness of psychosocial interventions on the reduction of 
depression and anxiety symptoms in a non-clinical population of SME 
employees. 
An important finding is the low number of robust studies on this 
topic. SMEs account for approximately 90% of businesses and over 50% 
of employees worldwide (World Bank Group, 2021), and the World 
Health Organization ranks depression as the largest single contributor to 
global disability and anxiety disorders as the sixth largest (World Health 
Organization, 2017). This is compounded by low treatment rates, with 
only one in five people in high-income countries and one in 27 in 
Table 1 (continued ) 
Author/ 
Year 
Study Design Population 
No. Started (No. 
Completers) 
Gender at Baseline SME Sector Intervention Intervention 
Intensity 
Country 
DVD + telephone 
support: 29% male/ 
71% female 
construction, transport, 
finance and others 
(n=115) 
2) self-administered 
DVD + resource 
kit + telephone support 
(n=78) 
3) active waitlist control 
group: psychoeducation- 
only DVD + resource kit 
(n=104) 
support of 6 x 
30-minute calls  
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low-/lower-/middle-income countries receiving adequate treatment for 
depression (Thornicroft et al., 2017). Therefore, there is a significant 
public health opportunity if this population can be reached and treated 
in a timely manner. While due to the lack of studies and their method-
ological limitations only preliminary conclusions can be drawn from our 
review, these first results may provide important early indicators and 
best practises for how to tackle depression and anxiety in the SME 
population. 
The results from the three RCTs (Blonk et al., 2006; Martin et al., 
2020; Saraf et al., 2019) show there is some evidence that CBT-based 
interventions can reduce symptoms of depression and anxiety in an 
SME setting, although further research is required to determine the most 
effective mode, duration and intensity of delivery. It is important to note 
that the RCTs (Blonk et al., 2006; Martin et al., 2020; Saraf et al., 2019) 
did not find significant differences between the CBT intervention and the 
control group in terms of effectiveness of reducing symptoms, and that 
Table 2 
Study findings.  
Results from Randomized Controlled Trials 
Author/Year Outcome Measure Evaluation Timepoints Main Findings QATQS 
Score 
Blonk et al. 
(2006) 
Symptoms of depression and anxiety 
(DASS) 
No. days until partial and full return to 
work 
Baseline, post-treatment (4 months), 10- 
month follow-up 
↓ in psychological complaints over time (p<0.01) in all 
arms of the study, no significant differences between 
intervention arms.  
Return to work: Combined intervention significantly more 
effective than CBT and control in achieving partial full 
return to work (d = 0.55 and d = 0.50 respectively, p<0.01, 
mean average 55 days sooner), and full return to work 
(Cohen’s d = 0.64 and d = 0.62 respectively, p<0.01, mean 
average 80 days sooner). Effect remained significant for full 
return to work only once gender, age, education, and the 
number of employees was adjusted for (p<0.01)  
Moderate 
Saraf et al. 
(2019) 
Symptoms of depression and anxiety 
(PHQ-ADS). 
Baseline, post-treatment (5 weeks), 3- 
month follow-up 
↓symptoms of depression and anxiety at 5 weeks (n.s.,¸p 
value not specified) and 3 months (p = 0.087) as compared 
to control group  
Moderate 
Martin et al. 
(2020) 
Psychological distress (K-10) Baseline, post-treatment (4 months) ↓psychological distress in self-administered plus telephone 
support group (p = 0.002) and active control group (p =
0.02); effect size greater in telephone support group 
compared to control (Hedge’s g = 0.35; CI [− 0.054, 
0.763]). No change in self-administered only arm (n.s., p 






Mental health diagnosis (PSE). 
Symptoms of depression (HAM-D), 
anxiety (HAM-A), global severity (SCL- 
90-R). 
Four assessments over 16 months: T0 (4 
months prior to baseline) T1 baseline, T2 
6-month follow-up, T3 12-month follow- 
up 
↓global severity, anxiety and depressive symptoms for 
clinical and subclinical cases comparing baseline with 12 
month follow up. 
Clinical cases: (d = 0.49, p<0.001 for depression; d = 0.50, 
p = 0.004 for anxiety; and d = 0.55, p<0.001 for global 
severity 
Subclinical cases: d = 0.40, p = 0.036 for depression; d =
0.46, p = 0.064 for anxiety; and d = 0.52, p = 0.041 for 
global severity 
Treatment refusers: significant ↓for depression (d = 0.29, p 
= 0.009) and global severity (d = 0.56, p = 0.002) but not 
anxiety despite the larger effect size (d = 0.82, p = 0.07) 
Healthy controls: no significant change in depressive 
symptoms (d = 0.12, p = 0.472), anxiety (d = 0.16, p =
0.096) or global severity (d = 0.19, p = 0.967).  
Weak 
Kim et al. 
(2014) 
Symptoms of depression (WSRI) Baseline and post-treatment (10 weeks) No statistically significant change in symptoms of 
depression: (d = 0.12, p = 0.247 for white-collar workers 





Self-reported absence or presence of 
depression 
Baseline, 1-year follow-up, 2-year follow- 
up 
↓depression at first follow-up in small businesses (OR =
0.71, 95% CI [0.55, 0.92]), with no significant change 
between first follow-up and second follow-up (OR=1.00, 
95% CI [0.50, 2.02]). ↓depression at first follow-up in 
small/medium businesses (OR = 0.91, 95% CI = 0.73, 1.14) 
and further reduction at second follow-up compared to first 
(OR=0.80, 95% CI [0.57, 1.11]). All adjusted for age and 
gender 
Moderate 
Demou et al. 
(2018) 
Symptoms of depression (HAM-D) and 
anxiety (HAM-A). 
Baseline and at discharge ↓symptoms of depression at discharge compared to baseline 
(p<0.001; d = 1.74, p<0.001 for all participants; d = 1.57, 
p<0.001 for participants presenting primarily with a 
mental health condition). ↓symptoms of anxiety (d = 0.90, 
p<0.001 for all; d = 1.80, p<0.001 for participants 
presenting primarily with a mental health condition)  
Moderate 
Note: DASS: Depression Anxiety Stress Scale; WSRI: Worker’s Stress Response Inventory; HAM-D: Hamilton Depression Scale; HAM-A: Hamilton Anxiety Scale; PHQ- 
ADS: Patient Health Questionnaire - Anxiety and Depression Scale; PSE: Present State Examination; SCL-90-R: Symptom Checklist-90-Revised; K10: Kessler-10 Psy-
chological Distress Scale. 
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symptom reduction was not based on a clinical diagnosis, meaning 
symptoms may have been mild with changes in scores difficult to detect. 
Effect sizes were largely unreported in the original studies but, where 
possible, were calculated by us and ranged from small to moderate. 
On the other hand, the study designs and effect sizes found in the 
non-RCT studies varied widely, which makes it difficult to generalise the 
findings. Face-to-face individual therapies showed positive results. 
Sørensen and colleagues found generally moderate effect sizes 
(Sørensen et al., 2019), similar to results for face-to-face interventions in 
the RCT by Blonk and colleagues (Blonk et al., 2006). In the study by 
Demou and colleagues (Demou et al., 2018), there were large effect sizes 
comparing baseline to six months follow-up, but the intervention ranged 
between telephone-based case management and face-to-face therapeutic 
support, making it hard to draw conclusions for the purposes of our 
review. Meanwhile, the study by Kim et al. (2014) found no significant 
effect of their intervention on depressive symptoms., 
Putting these results into the context of mental health interventions 
conducted in larger enterprises, the effectiveness of CBT-based in-
terventions is similar to that which has been found in companies of all 
sizes, where CBT is the most studied intervention and has been found to 
have greater or equal effectiveness when compared to other approaches 
(Carolan et al., 2017a; Naidu et al., 2016; Nigatu et al., 2019), although 
combining therapeutic approaches may increase effectiveness (Yunus 
et al., 2018). However, there may be important differences between 
large companies and SMEs in how the intervention is delivered. Small 
businesses have low take up of health promotion programmes (McCoy 
et al., 2014). While a study by Taylor and colleagues (Taylor et al., 2016) 
found that time and funding were major difficulties in implementing 
health promotion programmes in businesses of all sizes, small business 
managers were less likely to think that this activity belonged in the 
workplace. The studies included in this review may reflect the realities 
of the challenges in implementing programmes in SMEs, as in many 
cases the intervention was accessed offsite away from the workplace 
(Blonk et al., 2006; Demou et al., 2018; Saraf et al., 2019; Sørensen et al., 
2019), or the SME owner/manager could directly access the material for 
themselves (Martin et al., 2020). In only two interventions (Kim et al., 
2014; Schwatka et al., 2018) was material distributed via the company. 
In contrast, reviews of studies which have usually taken place in larger 
businesses show a larger number of interventions based specifically in 
the workplace (Nigatu et al., 2019; Yunus et al., 2018) although, similar 
to the studies led by Demou and Blonk, when workers are on sick leave, 
the intervention is evidently not workplace-based (Naidu et al., 2016). 
Attrition exceeded 40% in four out of the seven studies (Demou et al., 
2018; Martin et al., 2020; Schwatka et al., 2018; Sørensen et al., 2019). 
This figure is in line with that seen in previous studies in the SME 
population (Martin and LaMontagne, 2018), and generally higher 
compared to rates in companies of all sizes (Yunus et al., 2018). In larger 
companies, it was found that the integration of technological elements 
with therapist support reduced attrition, and a shorter time frame, 
engagement through mails and messaging, and persuasive technology 
such as self-monitoring could increase engagement and adherence 
(Carolan et al., 2017b; Yunus et al., 2018). These elements could be 
added to SME-based interventions in an effort to improve attrition rates. 
Some interventions were easier to implement affordably on a wide 
scale, such as those in a group setting or providing educational materials 
(Kim et al., 2014; Martin et al., 2020; Saraf et al., 2019; Schwatka et al., 
2018). The addition of telephone support appeared to be beneficial 
(Martin et al., 2020; Schwatka et al., 2018) and in line with findings in 
companies of all sizes (Yunus et al., 2018), and may be a cost-effective 
way to enhance effectiveness which warrants further research. Howev-
er, in the studies included in our review, there was a general lack of focus 
on the impact of interventions on occupational outcomes, which is in 
line with findings from a systematic meta-review in companies of all 
sizes (Joyce et al., 2016). Only two studies (Martin et al., 2020; Saraf 
et al., 2019) included the costs of their interventions and no study 
assessed its financial impact in terms of direct or indirect costs for 
companies, health services and the individual. This data would have 
been especially interesting in order to understand whether face-to-face 
interventions, which in our review had more robust effect sizes, have 
a sufficient impact on absenteeism and presenteeism to be cost-effective, 
especially in the context of SMEs where it can be especially difficult to 
organise cover for people who are off sick or underperforming due to 
mental health difficulties. 
Prevention, early recognition and treatment of anxiety and depres-
sive disorders are crucial aspects in improving prognosis (Craske and 
Stein, 2016; Kraus et al., 2019; Olobuka et al., 2018). In line with pre-
vious data that depression is undertreated (Thornicroft et al., 2017), in 
the study by Sørensen et al. (2019), 70% of those who had a clinical or 
subclinical mental disorder had never pursued or received treatment. 
These data highlight the imperative demand to provide workplace in-
terventions for prevention, identification and early treatment of 
depression and anxiety, in people who would otherwise not seek help. 
Future interventions could combine programmes delivered through the 
workplace with the use of more specialised treatment or local health 
resources for more severe cases, similar to the model used in some 
studies identified (Blonk et al., 2006; Demou et al., 2018; Sørensen et al., 
2019). Another interesting finding comes from the study by Blonk and 
colleagues (Blonk et al., 2006), in which the population were on sick 
leave with adjustment disorders. While both CBT-based interventions 
showed no difference in their effectiveness in reducing symptoms, the 
intervention which directly focused on return to work through advice on 
work processes achieved a significantly quicker return to work. This 
suggests that interventions in SME workers on sick leave should have 
return to work as a specific treatment objective. 
A strength of this review is the grey literature search in addition to 
our systematic search of a number of databases, as well as two specific 
occupational health databases, meaning we have aimed to include all 
possible research on this topic. Another strength is the diversity of 
geographical regions represented, suggesting that interventions for SME 
workers are acceptable in different cultural and socioeconomic areas. 
However, this work also has some limitations due to the small number of 
studies identified and methodological issues, due to which it was not 
possible to carry out a meta-analysis. Of importance is the lack of studies 
focusing on suicidal ideation and behaviour, or clinical anxiety and 
depression, as well as the reliance on self-report measures, and the high 
attrition. Several studies lacked a control group, which is necessary to 
test the effectiveness of the interventions. In those trials which included 
a control group, effect sizes of the beneficial outcomes of the interven-
tion group compared with the control group may have been inflated by 
nocebo responses from controls (Gold et al., 2017). Double blinding is 
difficult in this type of intervention and was not achieved by any of the 
studies, and thus represents a source of bias. There is also a risk for 
publication bias, which may further have biased the results, which we 
attempted to mitigate by searching for unpublished data. 
These limitations reflect flaws already highlighted in previous re-
views on the effectiveness of workplace-based interventions in com-
panies of all sizes, namely high heterogeneity in the type, length and 
mode of intervention, high risk of bias in the included studies (Carolan 
et al., 2017a; Wagner et al., 2016; Yunus et al., 2018), and a lack of focus 
on clinical diagnoses of anxiety or major depressive disorders (Dietrich 
et al., 2012). 
Putting the results into context, the preliminary data indicate that 
psychosocial interventions for depression and anxiety are feasible and 
acceptable in the SME workplace, as they are in larger workplaces, but 
there may be key differences in how these interventions should be 
designed and delivered in order to adapt to the specific SME context. 
Further research should focus on assessing the effectiveness of CBT or 
other evidence-based psychological interventions in SME employees 
with clinical anxiety and depression using large-scale RCTs. Research on 
the most cost-effective mode of delivery, as well as increasing engage-
ment and reducing attrition, could improve outcomes. A greater focus on 
financial and occupational outcomes would help identify which 
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interventions are most cost-effective for SME companies with strained 
resources. Research into this area is especially timely given the general 
increase in symptoms of depression and anxiety caused by the COVID-19 
pandemic (COVID-19 Psychological Research Consortium, 2020), as 
well as the economic uncertainty in its wake (Nicola et al., 2020) 
disproportionately affecting SMEs (OECD, 2020). 
To try to address this need, the MENTUPP intervention is being 
developed (https://www.mentuppproject.eu/). MENTUPP is a project 
sponsored by a European Union H2020 grant, created with the primary 
aim of improving mental health in the workplace by developing, 
implementing and evaluating a multilevel intervention in SMEs, to 
reduce depression, anxiety and suicide, as well as non-clinical conditions 
such as burnout and stress, across EU countries and Australia. 
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